A detailed history of Gamma Investing LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 271 shares of ITOS stock, worth $2,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares
271
Previous 209 29.67%
Holding current value
$2,203
Previous $3.1 Million 10.8%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$10.09 - $17.97 $625 - $1,114
62 Added 29.67%
271 $2.77 Million
Q2 2024

Jul 02, 2024

BUY
$10.33 - $18.09 $630 - $1,103
61 Added 41.22%
209 $3.1 Million
Q1 2024

Apr 05, 2024

BUY
$9.89 - $13.64 $148 - $204
15 Added 11.28%
148 $2.02 Million
Q4 2023

Feb 01, 2024

BUY
$8.57 - $11.06 $1,139 - $1,470
133 New
133 $1.32 Million

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $289M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.